Last reviewed · How we verify
NCT01353417
A Single-site, Prospective Non-interventional-study With Adport Sandoz© Capsules for Prophylaxis of Graft Rejection in Patients With Stable Kidney Function After Renal Allograft.
trial testing In this observational study no study specific intervention is planned in Chronic Kidney Insufficiency in 102 participants. Completed in 31 August 2015.
31 August 2015
Quick facts
| Lead sponsor | Sandoz |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 102 |
| Start date | 1 April 2011 |
| Primary completion | 31 August 2015 |
| Estimated completion | 31 August 2015 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- In this observational study no study specific intervention is planned
Conditions studied
- Chronic Kidney Insufficiency — all drugs for Chronic Kidney Insufficiency →
Sponsor
Sandoz — full company profile →
Who can join
18 and older, any sex, with Chronic Kidney Insufficiency. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
Changes in Adport Sandoz© trough level
Time frame: Observation time: 26 weeks
Sponsor's own description
This non-interventional study intends to collect epidemiological data in patients with stable kidney function after renal transplantation, who receive Tacrolimus Sandoz© according to the approved indication.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT01353417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Insufficiency
Currently open trials in the same condition.
- NCT06886256 — Prehabilitation for Kidney Transplant Candidates · NA · recruiting
- NCT06238310 — Comparison of Two Different External Clearance Markers - Mannitol and Iohexol for Measuring Glomerular Filtration Rate · NA · recruiting
- NCT04334707 — Kidney Precision Medicine Project · recruiting
- NCT03991169 — Oral Iron in Children With Chronic Kidney Disease · Phase 4 · recruiting
Other Sandoz trials
Trials by the same sponsor.
- NCT06847724 — Comparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Partici · Phase 3 · recruiting
- NCT06587451 — Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Propo · Phase 3 · terminated
- NCT05070650 — Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold · Phase 3 · withdrawn
- NCT06159790 — A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With · Phase 3 · completed
- NCT05887843 — Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and · Phase 1 · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01353417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sandoz
- Last refreshed: 5 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01353417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing